SIP
ACHV icon

Stoneridge Investment Partners’s Achieve Life Sciences ACHV Stock Holding History

Stoneridge Investment Partners’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-27
Closed -$73K – 286
2015
Q4 		$73K Sell
27
-5
-16% -$21.1K 0.01% 272
2015
Q3 		$156K Hold
32
– – 0.02% 266
2015
Q2 		$165K Buy
32
+9
+39% +$44.6K 0.02% 265
2015
Q1 		$111K Buy
23
+1
+5% +$4.91K 0.01% 259
2014
Q4 		$113K Buy
22
+4
+22% +$19.6K 0.01% 246
2014
Q3 		$106K Buy
18
+9
+100% +$62.5K 0.02% 239
2014
Q2 		$71K Hold
9
– – 0.01% 225
2014
Q1 		$232K Hold
9
– – 0.04% 180
2013
Q4 		$165K Hold
9
– – 0.03% 195
2013
Q3 		$184K Buy
9
+2
+29% +$41.4K 0.04% 190
2013
Q2 		$157K Buy
+7
New +$157K 0.04% 177

Other funds holding ACHV

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stoneridge Investment Partners's ACHV Position: Q1 2016 in Review

Stoneridge Investment Partners sold out of Achieve Life Sciences (ACHV) in Q1 2016, closing a stake of 27 shares — an estimated $73K sold.

Stoneridge Investment Partners first reported a position in ACHV in Q2 2013 and held it in 11 quarters. The position peaked at $232K in Q1 2014. 38 funds tracked by Wall St. Rank hold ACHV as of Q1 2016.

  • Stoneridge Investment Partners reported no remaining Achieve Life Sciences position as of Q1 2016 after selling out during the quarter.
  • Stoneridge Investment Partners sold 27 Achieve Life Sciences shares in Q1 2016, an estimated $73K.
  • Stoneridge Investment Partners first reported a position in Achieve Life Sciences in Q2 2013 and held it in 11 quarters.
  • Stoneridge Investment Partners's Achieve Life Sciences position peaked at $232K in Q1 2014.
  • 38 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2016.

Based on Stoneridge Investment Partners's 13F filing for Q1 2016, filed 29 Apr 2016.